FERNANDO
MORENO ANTÓN
Profesor asociado de Ciencias de la Salud
Harvard Medical School
Boston, Estados UnidosHarvard Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Assessment of a Genomic Assay in Patients with ERBB2 -Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy with or Without Pertuzumab
JAMA Oncology, Vol. 9, Núm. 6, pp. 841-846